📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial. (2022)

First Author: ACTIV-3/TICO Bamlanivimab Study Group

Attributed to: Respiratory infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7326/m21-3507

PubMed Identifier: 34928698

Publication URI: http://europepmc.org/abstract/MED/34928698

Type: Journal Article/Review

Volume: 175

Parent Publication: Annals of internal medicine

Issue: 2

ISSN: 0003-4819